Evidence for a pre-latent form of the serpin plasminogen activator inhibitor-1 with a detached β-strand 1C

被引:36
作者
Dupont, Daniel M.
Blouse, Grant E.
Hansen, Martin
Mathiasen, Lisa
Kjelgaard, Signe
Jensen, Jan K.
Christensen, Anni
Gils, Ann
Declerck, Paul J.
Andreasen, Peter A.
Wind, Troels
机构
[1] Aarhus Univ, Dept Mol Biol, Lab Cellular Prot Sci, DK-8000 Aarhus C, Denmark
[2] Katholieke Univ Leuven, Fac Pharmaceut Sci, Lab Pharmaceut Biol, B-3000 Louvain, Belgium
关键词
D O I
10.1074/jbc.M606851200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Latency transition of plasminogen activator inhibitor-1 (PAI-1) occurs spontaneously in the absence of proteases and results in stabilization of the molecule through insertion of its reactive center loop (RCL) as a strand in beta-sheet A and detachment of beta-strand 1C (s1C) at the C-terminal hinge of the RCL. This is one of the largest structural rearrangements known for a folded protein domain without a concomitant change in covalent structure. Yet, the sequence of conformational changes during latency transition remains largely unknown. We have now mapped the epitope for the monoclonal antibody H4B3 to the cleft revealed upon s1C detachment and shown that H4B3 inactivates recombinant PAI-1 in a time-dependent manner. With fluorescence spectroscopy, we show that insertion of the RCL is accelerated in the presence of H4B3, demonstrating that the loss of activity is the result of latency transition. Considering that the epitope for H4B3 appears to be occluded by s1C in active PAI-1, this finding suggests the existence of a pre-latent conformation on the path from active to latent PAI-1 characterized by at least partial detachment of s1C. Functional characterization of mutated PAI-1 variants suggests that a salt-bridge between Arg(273) and Asp(224) may stabilize the pre-latent conformation. The binding of H4B3 and of a peptide targeting the cleft revealed upon s1C detachment was hindered by the glycans attached to Asn(267). Conclusively, we have provided evidence for the existence of an equilibrium between active PAI-1 and a pre-latent form, characterized by reversible detachment of s1C and formation of a glycan-shielded cleft in the molecule.
引用
收藏
页码:36071 / 36081
页数:11
相关论文
共 43 条
[41]   Mutational analysis of plasminogen activator inhibitor-1 -: Interactions of α-helix F and its neighbouring structural elements regulates the activity and the rate of latency transition [J].
Wind, T ;
Jensen, JK ;
Dupont, DM ;
Kulig, P ;
Andreasen, PA .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2003, 270 (08) :1680-1688
[42]   Epitope mapping for four monoclonal antibodies against human plasminogen activator inhibitor type-1 - Implications for antibody-mediated PAI-1-neutralization and vitronectin-binding [J].
Wind, T ;
Jensen, MA ;
Andreasen, PA .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (04) :1095-1106
[43]   Interfering with the inhibitory mechanism of serpins:: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide [J].
Xue, YF ;
Björquist, P ;
Inghardt, T ;
Linschoten, M ;
Musil, D ;
Sjölin, L ;
Deinum, J .
STRUCTURE WITH FOLDING & DESIGN, 1998, 6 (05) :627-636